Eddii, inc.
New York, 10016, United States
NCT Number: NCT05205876
The study is designed to measure the safety and feasibility of the Eddii mobile app for children living with Type-1 diabetes and using a CGM (Continuous Glucose monitor).
Looking for future studies?
Notify Me5 year–12 year
All sexes
Interventional
Not applicable
New York, 10016, United States
Wearable continuous glucose monitoring (CGM) sensors have revolutionized diabetes management over the past decade. By providing blood glucose (BG) concentration measurements continuously over consecutive days, CGMs are an increasingly adopted technology. While CGM devices have been shown to improve the safety and effectiveness of diabetes therapy to reduce hypoglycemia incidents and durability and to decrease glycemic variability CGM software and tools available for users to feel motivated and engaged are limited. Users of CGM often use an app that provides an interface for them to track their BG. In most cases, this app is offered by their CGM device provider.
These interfaces are considerably basic and scientific in nature, often developed by scientists and engineers for the everyday user. These apps are particularly dull and tiresome for children and adolescents living with diabetes. Current real-time CGM interfaces present real-time BG reading, in addition to the BG trend and a historical chart, together with minimal options for the user to enter lifestyle data such as medications, meals, and exercise. Examples of such default interfaces are ones offered by Dexcom, Medtronic Guardian and Freestyle Libre. While some of these apps provide patterns and health summaries to the user, these are provided in a separate app to the one streaming real-time BG. With the emergence of rtAPI (real-time Application Programming Interface) integrations with CGMs, there is ample opportunity to improve the dynamism, sophistication, and offerings within these CGM Apps , creating a platform that delights the user rather than one that makes diabetes management seem like a daily chore. Furthermore, it is hypothesized that creating additional engagement in the form of games and real-life rewards will improve glycemic control.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Pediatric Volunteers)
Subject must meet all of the following to be enrolled.
Parent / Guardian Volunteers:
Subject must meet all of the following to be enrolled.
Exclusion criteria
Subject will be excluded if any of the below are present.
Exclusion criteria
(Parents / Guardians) Subject will be excluded if any of the below are present.
Participants will use the Eddii mobile application in the intervention arm.
Time frame: Eight Weeks
Safety (Intervention Arm only) as assessed by:
○ Functionality and reliability of Eddii application by measuring reported faults
Time frame: Four Weeks
Feasibility (Intervention Arm only) as measured by:
Time frame: Eight Weeks
Time frame: Eight Weeks
Time frame: Eight Weeks
App-Specific Measures for Entirety of Study (Intervention Arm only)
○ Engagement and retention of users
Eddii, Inc.
Industry
A Safety and Feasibility Study of the Eddii Mobile Application for Glucose Monitoring in Pediatric Patients With Type I Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02862860
Type-1 Diabetes
Dijon, France
View Trial DetailsNCT01519102
Type-1 Diabetes
Montreal, Quebec, Canada
View Trial DetailsNCT06287840
Behavior, Motor Activity
Saskatoon, Saskatchewan, Canada
View Trial Details